Indomethacin enhances serum 2′5′-oligoadenylate synthetase in patients with hepatitis B and C virus chronic active hepatitis

Journal of Hepatology

Volumn 21, Issue 6, 1994, Pages 984-988

  Andreone, Pietro ^a   Cursaro, Carmela ^a   Gramenzi, Annagiulia ^a   Buzzi, Andrea ^a   Miniero, Rita ^b   Sprovieri, Giuseppe ^b   Gasbarrini, Giovanni ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Arachidonic acid; Chronic viral hepatitis; Cyclooxygenase; Indomethacin; Interferon ; Nonsteroid anti inflammatory drugs; Oligoadenylate synthetase; Prostaglandins

Indexed keywords

2',5' OLIGOADENYLATE SYNTHETASE; ALPHA INTERFERON; ALPHAN1 INTERFERON; ARACHIDONIC ACID; HEPATITIS B(E) ANTIGEN; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN;

ADULT; ARTICLE; CHRONIC ACTIVE HEPATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG INTERACTION; FEMALE; HEARTBURN; HEPATITIS B; HEPATITIS C; HUMAN; INFLUENZA; MALE; ORAL DRUG ADMINISTRATION; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

2',5'-OLIGOADENYLATE SYNTHETASE; ADOLESCENT; ADULT; DRUG COMBINATIONS; FEMALE; HEPATITIS ANTIBODIES; HEPATITIS B; HEPATITIS B E ANTIGENS; HEPATITIS C; HEPATITIS, CHRONIC; HUMANS; INDOMETHACIN; INTERFERON-ALPHA; MALE; MIDDLE AGED; OSMOLAR CONCENTRATION;

EID: 0028652298     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(05)80606-3     Document Type: Article

References (18)

1. Anti-mitogenic function of interferon induced (2′–5′) oligoadenylate and growth related variations in enzymes that synthesize and degrade this oligonucleotide
2. Signal transduction by interferon-α through arachidonic acid metabolism
3. Serum 2′,5′-oligoadenylate synthetase activity during interferon treatment of chronic hepatitis B
4. 2 metabolite rise in acute viral hepatitis (Abstract)
5. 2 on defective interferon-γ production during type B acute viral hepatitis
6. 2 production by cultured liver biopsy in patients with chronic viral hepatitis: can NSAIDs improve the therapeutic response to IFN-α?
7. 2 acts at two distinct pathways of T lymphocyte activation: inhibition of interleukin 2 production and down-regulation of transferrin receptor expression
8. Mitogen-induced changes in lymphocyte prostaglandin levels: a signal for the induction of suppressor cell activity
9. 2-induced inhibition of interleukin 2 production
10. Prostaglandin E inhibits the production of human interleukin 2
11. The mechanism of inhibition of human IL 2 production
12. Regulation of in vitro human leukocyte interferon production: effect of prostaglandin synthetase and phosphodiesterase inhibition
13. Characteristics of cyclosporine induction of increased prostaglandin levels from human peripheral blood monocytes
14. Interferon-γ production by peripheral blood mononuclear cells of patients with chronic liver disease
15. Interferon signalling through arachidonic acid-dependent pathways: a clue to adjuvant therapy for chronic viral hepatitis?
16. Interferon-α therapy combined with nonsteroid anti-inflammatory drugs for treatment of chronic viral hepatitis?
17. Indomethacin-enhanced immunotherapy of pulmonary metastases using IL-2 and IFN-α
18. An evaluation of recombinant leukocyte α interferon with aspirin in patients with metastatic renal cell cancer